Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Libtayo (cemiplimab)
pCPA File Number:
21148
Negotiation Status:
Concluded with an LOI
Indication(s):
Cutaneous Squamous Cell Carcinoma
Sponsor/Manufacturer:
Sanofi Genzyme
CADTH Project Number:
pCODR 10187
pCPA Engagement Letter Issued:
2020-06-08
Negotiation Process Concluded:
2020-11-04